Cargando…

Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype

BACKGROUND: Dicer, a ribonuclease, is the key enzyme required for the biogenesis of microRNAs and small interfering RNAs and is essential for both mammalian development and cell differentiation. Recent evidence indicates that Dicer may also be involved in tumourigenesis. However, no studies have exa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grelier, G, Voirin, N, Ay, A-S, Cox, D G, Chabaud, S, Treilleux, I, Léon-Goddard, S, Rimokh, R, Mikaelian, I, Venoux, C, Puisieux, A, Lasset, C, Moyret-Lalle, C
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736830/ https://www.ncbi.nlm.nih.gov/pubmed/19672267 http://dx.doi.org/10.1038/sj.bjc.6605193

Ejemplares similares

Complexity in the regulation of Dicer expression: Dicer variant proteins are differentially expressed in epithelial and mesenchymal breast cancer cells and decreased during EMT
por: Hinkal, G W, et al.
Publicado: (2011)

Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancer
por: Drouet, Youenn, et al.
Publicado: (2018)

Absence of p300 induces cellular phenotypic changes characteristic of epithelial to mesenchyme transition
por: Krubasik, D, et al.
Publicado: (2006)

Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells
por: Comamala, M, et al.
Publicado: (2011)

Epithelial-mesenchymal transition-like events in vulvar cancer and its relation with HPV
por: Rodrigues, I S, et al.
Publicado: (2013)

Disabled-2 downregulation promotes epithelial-to-mesenchymal transition
por: Martin, J C, et al.
Publicado: (2010)

Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers
por: Green, A R, et al.
Publicado: (2013)

Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells
por: Ricciardi, M, et al.
Publicado: (2015)

NF-κB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells
por: Vonach, C, et al.
Publicado: (2011)

Tumour-initiating capacity is independent of epithelial–mesenchymal transition status in breast cancer cell lines
por: Xie, G, et al.
Publicado: (2014)

New cellular tools reveal complex epithelial–mesenchymal interactions in hepatocarcinogenesis
por: Sagmeister, S, et al.
Publicado: (2008)

Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer
por: Lundgren, K, et al.
Publicado: (2009)

MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients
por: Pichler, M, et al.
Publicado: (2014)

Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature
por: D′Amico, L, et al.
Publicado: (2013)

CD44s signals the acquisition of the mesenchymal phenotype required for anchorage-independent cell survival in hepatocellular carcinoma
por: Okabe, H, et al.
Publicado: (2014)

Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation
por: Liotta, F, et al.
Publicado: (2015)

Impact of cellular folate status and epidermal growth factor receptor expression on BCRP/ABCG2-mediated resistance to gefitinib and erlotinib
por: Lemos, C, et al.
Publicado: (2009)

Sox11 expression in astrocytic gliomas: correlation with nestin/c-Met/IDH1-R132H expression phenotypes, p-Stat-3 and survival
por: Korkolopoulou, P, et al.
Publicado: (2013)

Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer
por: Loddo, M, et al.
Publicado: (2009)

Characterisation and protein expression profiling of annexins in colorectal cancer
por: Duncan, R, et al.
Publicado: (2008)

Direct T cell–tumour interaction triggers T(H)1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme
por: Jin, P, et al.
Publicado: (2014)

Expression of Ksp-cadherin during kidney development and in renal cell carcinoma
por: Thedieck, C, et al.
Publicado: (2005)

ERK5 signalling in prostate cancer promotes an invasive phenotype
por: Ramsay, A K, et al.
Publicado: (2011)

Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas
por: Colomiere, M, et al.
Publicado: (2009)

Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
por: Yu, Y, et al.
Publicado: (2014)

Digital pattern recognition-based image analysis quantifies immune infiltrates in distinct tissue regions of colorectal cancer and identifies a metastatic phenotype
por: Angell, H K, et al.
Publicado: (2013)

Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer
por: Carpenter, B, et al.
Publicado: (2006)

Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma
por: Kontos, C K, et al.
Publicado: (2010)

The T1799A point mutation is present in posterior uveal melanoma
por: Janssen, C S, et al.
Publicado: (2008)

Prognostic significance of epithelial–mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray
por: Nitta, T, et al.
Publicado: (2014)

Mitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility
por: Challen, C, et al.
Publicado: (2011)

The in situ local immune response, tumour senescence and proliferation in colorectal cancer
por: Roxburgh, C S, et al.
Publicado: (2013)

Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance
por: Gerlach, M M, et al.
Publicado: (2014)

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer
por: Hofstetter, G, et al.
Publicado: (2011)

Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx
por: Junor, E, et al.
Publicado: (2012)

Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
por: Kristiansen, G, et al.
Publicado: (2010)

Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis: diagnostic and prognostic value
por: Lomnytska, M I, et al.
Publicado: (2011)

Impact of genomic stability on protein expression in endometrioid endometrial cancer
por: Lomnytska, M I, et al.
Publicado: (2012)

Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study
por: Aparicio, T, et al.
Publicado: (2013)

Cancer phenotype as the outcome of an evolutionary game between normal and malignant cells
por: Dingli, D, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_bbnut0ao8rup541sr4ui8td739